{
    "nctId": "NCT03024463",
    "briefTitle": "The Multi-center Validation Study of Internal Mammary Lymph Biopsy With Modified Injection Technique in Breast Cancer Patients",
    "officialTitle": "The Multi-center Validation Study of Breast Cancer Internal Mammary Lymph Biopsy",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasm",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "The accuracy (false negative rate) of internal mammary sentinel lymph node biopsy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with preoperative pathology confirmed invasive breast cancer;\n* Clinical N1-3 M0 (with positive fine-needle aspiration result in their clinical or ultrasonic suspicious axillary lymph node ; no clinical or radiologic evidence of distant metastases);\n* Be able and willing to sign informed consent forms.\n\nExclusion Criteria:\n\n* Patients who have received neoadjuvant therapy (including neoadjuvant chemotherapy and / or endocrine therapy);\n* Patients with a previous history of breast cancer (recurrence of breast cancer and contralateral breast cancer);\n* Patients with a history of other malignancies;\n* Patients who have had previous surgery in axillary or internal mammary;\n* Patients in pregnancy and lactation;\n* Patients participant in other clinical trials that will have an impact on the results of this study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}